LDN193189, GMP Grade
| Cat.No. : | LDN193189-17 |
| Product Overview : | LDN193189 (DM-3189) (GMP) is LDN193189 produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. |
- Specification
- Gene Information
- Related Products
- Download
| Description : | LDN193189 is selective BMP type I receptor inhibitor. |
| Form : | Solid, White to yellow |
| Target : | TGF-β Receptor |
| In Vitro : | LDN193189 (GMP) (250 nM; 0-7 d) induces human pluripotent stem cells (hPSC) directly differentiates into midbrain dopamine neurons (mDA). LDN193189 (GMP) (200 nM) induces the generation of glucose-responsive β cells from hPSCs in vitro. |
| CAS : | 1062368-24-4 |
| Formula : | C25H22N6 |
| Molecular Mass : | 406.49 |
| Storage : | 4 centigrade, sealed storage, away from moisture and light |
| Pathway | TGF-beta/Smad |
| Official Symbol | LDN193189 |
| Synonyms | LDN193189; DM-3189 |
| ◆ Recombinant Proteins | ||
| LDN193189-17 | LDN193189, GMP Grade | +Inquiry |
Not For Human Consumption!
Inquiry
- Reviews
- Q&As
Ask a Question for All LDN193189 Products
Required fields are marked with *
My Review for All LDN193189 Products
Required fields are marked with *
0
Inquiry Basket
